BioXcel Therapeutics, Inc. (BTAI) NASDAQ
1.13
-0.01(-0.88%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.13
-0.01(-0.88%)
Currency In USD
| Market Cap | 19.53M |
| Enterprise Value | 100.71M |
| P/E Ratio | -0.18 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 51.31 |
| Price/Book Ratio | -0.13 |
| Enterprise/Revenue | 173.53 |
| Enterprise/EBITDA | -1.98 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -110.79 |
| Operating Margin | -73.95 |
| Return On Assets | -2.21 |
| Return On Equity | 0.76 |
| Revenue | 642,000 |
| Revenue/Share | 0.06 |
| Gross Profit | 478,000 |
| EBITDA | -52.61M |
| Net Income | -69.9M |
| Diluted EPS | -5.73 |
| Total Cash | 17.18M |
| Total Cash/Share | 1.41 |
| Total Debt | 100.29M |
| Total Debt/Equity | -0.95 |
| Current Ratio | 0.62 |
| Book Value Per Share | -8.65 |
| 52-Week Change | -18.71 |
| 52-Week High | 8.08 |
| 52-Week Low | 1.01 |
| Moving Average 50 Days | 1.23 |
| Moving Average 200 Days | 2.13 |
| Average Volume | 1.59M |
| Shares Outstanding | 30.88M |
| % Held by Institutions | 44.56 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:16 |
| Last Split Date | February 10, 2025 |